PHG
Koninklijke Philips NV ADR
$27.74+1.99%
Setup
Watch
Buy Zone
$28.31-$29.73
Sector
Medical Devices
Industry
Medical Devices
48
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
PHG chart
Loading chart…
Overall Quality48
RS Rating
46
relative strength
Fundamentals
62
Solid fund-Q
Volume Demand
82
-20% vs avg
Technical Setup
63
5/8 checks
Industry/Theme
91
Medical Devices
Trade Plan
Avoid
Entry
$28.31
Entry Zone
$28.31-$29.73
Stop / Risk
$26.05
RS Rating
46
Volume confirmed
Yes
Targets
$33.97 / $35.39
Breakout · IBD Setup
3 ✓ 5 ✗
Entry $28.31–$29.73Stop $26.05Target $33.97 / $35.39
Market regimeRange
Quality48
RS Rating46
Above 50-MA+4.3%
Above 200-MA-0.74%
VolumeConfirmed
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
48
MarketRange
SetupWatch
ConfidenceExperimental · not backtested
Fund-Q62 · Solid
StatusAvoid
Stock Data
52-Week Range24 – 33
Price % Chg YTD2.44%
Price % Chg 4wk9.08%
50-Day Avg Vol1.2 Mil
P/E Ratio23.3
Market Cap$26B
SectorHealthcare
IndustryMedical Devices
Company Fundamentals
EPS % Chg (Qtr)113.83%
Sales % Chg (Qtr)5.95%
EPS Growth 5y-4.98%
Sales Growth 5y0.39%
Annual ROE8.7%
Gross Margin45.19%
Operating Margin9.37%
Net Margin5.49%
Debt / Equity0.71
Setup levels
Current price
$27.74
Pivot
$28.31
Distance to buy
-17%
52-week range
23.75-33.43
Trigger evidence
No active trigger evidence available.
Pattern levels: near highs
Financial health checks
3/5
Return on equity above 15%
ROE 8.7%
Net margin above 10%
Net margin 5.49%
EPS growing quarter on quarter
EPS q/q 113.83%
Sales growing quarter on quarter
Sales q/q 5.95%
Debt to equity below 1.0
D/E 0.71
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE8.7%
vs sector -14.3%
Net margin5.49%
vs sector -13.8%
Gross margin45.19%
vs sector -26.5%
EPS growth q/q113.83%
vs sector +94.6%
Sales growth q/q5.95%
vs sector -15.2%
Debt / equity0.71
vs sector -0.01
Business quality
62
GradeSolid
EPS rating80
P/E23.3
Market cap$26B
IndustryMedical Devices
Technical checks
Über 50-MA
Pass
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Pass
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-06-25
Trigger date
—
Days on list
9
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.